Correlation Between Oncternal Therapeutics and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Oncternal Therapeutics and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncternal Therapeutics and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncternal Therapeutics and Seres Therapeutics, you can compare the effects of market volatilities on Oncternal Therapeutics and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncternal Therapeutics with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncternal Therapeutics and Seres Therapeutics.
Diversification Opportunities for Oncternal Therapeutics and Seres Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Oncternal and Seres is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Oncternal Therapeutics and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Oncternal Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncternal Therapeutics are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Oncternal Therapeutics i.e., Oncternal Therapeutics and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Oncternal Therapeutics and Seres Therapeutics
Given the investment horizon of 90 days Oncternal Therapeutics is expected to under-perform the Seres Therapeutics. In addition to that, Oncternal Therapeutics is 1.22 times more volatile than Seres Therapeutics. It trades about -0.26 of its total potential returns per unit of risk. Seres Therapeutics is currently generating about 0.18 per unit of volatility. If you would invest 70.00 in Seres Therapeutics on August 28, 2024 and sell it today you would earn a total of 19.00 from holding Seres Therapeutics or generate 27.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncternal Therapeutics vs. Seres Therapeutics
Performance |
| Timeline |
| Oncternal Therapeutics |
| Seres Therapeutics |
Oncternal Therapeutics and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncternal Therapeutics and Seres Therapeutics
The main advantage of trading using opposite Oncternal Therapeutics and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncternal Therapeutics position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Oncternal Therapeutics vs. CytomX Therapeutics | Oncternal Therapeutics vs. Assembly Biosciences | Oncternal Therapeutics vs. Instil Bio | Oncternal Therapeutics vs. Nuvation Bio |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |